378 related articles for article (PubMed ID: 2856171)
21. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
22. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
Mayeux PR; Mais DE; Carr C; Halushka PV
J Pharmacol Exp Ther; 1989 Sep; 250(3):923-7. PubMed ID: 2528631
[TBL] [Abstract][Full Text] [Related]
23. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).
Kattelman EJ; Venton DL; Le Breton GC
Thromb Res; 1986 Feb; 41(4):471-81. PubMed ID: 3008368
[TBL] [Abstract][Full Text] [Related]
24. Binding of thromboxane A2/prostaglandin H2 agonists to human platelets.
Halushka PV; Kochel PJ; Mais DE
Br J Pharmacol; 1987 May; 91(1):223-7. PubMed ID: 3594077
[TBL] [Abstract][Full Text] [Related]
25. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
26. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
27. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
[TBL] [Abstract][Full Text] [Related]
29. Purification and characterization of the human platelet TXA2/PGH2 receptor.
Narumiya S; Ushikubi F; Nakajima M; Hirata M; Okuma M
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():339-46. PubMed ID: 1825566
[No Abstract] [Full Text] [Related]
30. Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor.
Mayeux PR; Mais DE; Halushka PV
Eur J Pharmacol; 1991 Jan; 206(1):15-21. PubMed ID: 1712307
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
[TBL] [Abstract][Full Text] [Related]
32. Characterization of thromboxane A2/prostaglandin H2 receptors in human vascular smooth muscle cells.
Morinelli TA; Mais DE; Oatis JE; Crumbley AJ; Halushka PV
Life Sci; 1990; 46(24):1765-72. PubMed ID: 2141663
[TBL] [Abstract][Full Text] [Related]
33. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.
Halushka PV; Mais DE; Saussy DL
Fed Proc; 1987 Jan; 46(1):149-53. PubMed ID: 2948839
[TBL] [Abstract][Full Text] [Related]
34. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors.
Bayon Y; Croset M; Daveloose D; Guerbette F; Chirouze V; Viret J; Kader JC; Lagarde M
J Lipid Res; 1995 Jan; 36(1):47-56. PubMed ID: 7706947
[TBL] [Abstract][Full Text] [Related]
35. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145.
Hanasaki K; Nagasaki T; Arita H
Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906
[TBL] [Abstract][Full Text] [Related]
36. pH-dependent binding of the TXA2/PGH2-receptor of human platelet membranes to various ligands.
Theis JG; Dellweg H; Perzborn E; Gross R
Agents Actions Suppl; 1992; 37():222-7. PubMed ID: 1385924
[TBL] [Abstract][Full Text] [Related]
37. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
Johnson GJ; Dunlop PC; Leis LA; From AH
Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
[TBL] [Abstract][Full Text] [Related]
38. Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes.
Saussy DL; Mais DE; Burch RM; Halushka PV
J Biol Chem; 1986 Mar; 261(7):3025-9. PubMed ID: 3005276
[TBL] [Abstract][Full Text] [Related]
39. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
Matsuda K; Mathur RS; Duzic E; Halushka PV
Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
[TBL] [Abstract][Full Text] [Related]
40. Photoaffinity labelling of a thromboxane A2/prostaglandin H2 antagonist binding site in human platelets.
Mais DE; Burch RM; Oatis JE; Knapp DR; Halushka PV
Biochem Biophys Res Commun; 1986 Oct; 140(1):128-33. PubMed ID: 2946292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
